Springworks Therapeutics, INC Form 4 insider transactions
Saqib Islam, CEO of SpringWorks Therapeutics, sold shares of common stock under a pre-arranged trading plan and corrected a previous underreporting of share ownership.
Director Julie Hambleton sold shares of SpringWorks Therapeutics (SWTX) on June 3, 2024, under a pre-arranged trading plan.
Badreddin Edris, Chief Operating Officer of SpringWorks Therapeutics, sold shares of common stock on June 3, 2024, under a pre-arranged trading plan.
Director Daniel Lynch received restricted stock units and stock options from SpringWorks Therapeutics as part of the company's non-employee director compensation policy.
Director Freda Lewis-Hall reports acquisition of SpringWorks Therapeutics stock and options as part of the company's non-employee director compensation policy.
Julie Hambleton, a director at SpringWorks Therapeutics, received stock and option grants as part of the company's non-employee director compensation policy.
Form 4: SpringWorks Therapeutics Director Alan Fuhrman Receives Stock Options and Restricted Stock Units
Director Alan Fuhrman received stock options and restricted stock units from SpringWorks Therapeutics as part of the company's non-employee director compensation policy.
Director Carlos Alban received restricted stock units and stock options from SpringWorks Therapeutics as part of the company's non-employee director compensation policy.
Bhavesh Ashar, Chief Commercial Officer of SpringWorks Therapeutics, reports the withholding of shares to cover tax obligations related to vesting restricted stock units.